Literature DB >> 28039581

MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells.

Guido Sebastiani1,2, Marco Valentini1,2, Giuseppina Emanuela Grieco1,2, Giuliana Ventriglia1,2, Laura Nigi1,2, Francesca Mancarella1,2, Silvia Pellegrini3, Gianvito Martino4, Valeria Sordi3, Lorenzo Piemonti3, Francesco Dotta5,6.   

Abstract

AIMS: MicroRNAs are a class of small noncoding RNAs, which control gene expression by inhibition of mRNA translation. MicroRNAs are involved in the control of biological processes including cell differentiation. Here, we aim at characterizing microRNA expression profiles during differentiation of human induced pluripotent stem cells (hiPSCs) into insulin-producing cells.
METHODS: We differentiated hiPSCs toward endocrine pancreatic lineage following a 18-day protocol. We analyzed genes and microRNA expression levels using RT real-time PCR and TaqMan microRNA arrays followed by bioinformatic functional analysis.
RESULTS: MicroRNA expression profiles analysis of undifferentiated hiPSCs during pancreatic differentiation revealed that 347/768 microRNAs were expressed at least in one time point of all samples. We observed 18 microRNAs differentially expressed: 11 were upregulated (miR-9-5p, miR-9-3p, miR-10a, miR-99a-3p, miR-124a, miR-135a, miR-138, miR-149, miR-211, miR-342-3p and miR-375) and 7 downregulated (miR-31, miR-127, miR-143, miR-302c-3p, miR-373, miR-518b and miR-520c-3p) during differentiation into insulin-producing cells. Selected microRNAs were further evaluated during differentiation of Sendai-virus-reprogrammed hiPSCs using an improved endocrine pancreatic beta cell derivation protocol and, moreover, in differentiated NKX6.1+ sorted cells. Following Targetscan7.0 analysis of target genes of differentially expressed microRNAs and gene ontology classification, we found that such target genes belong to categories of major significance in pancreas organogenesis and development or exocytosis.
CONCLUSIONS: We detected a specific hiPSCs microRNAs signature during differentiation into insulin-producing cells and demonstrated that differentially expressed microRNAs target several genes involved in pancreas organogenesis.

Entities:  

Keywords:  Diabetes; Insulin-producing cells; iPSC; microRNAs

Mesh:

Substances:

Year:  2016        PMID: 28039581     DOI: 10.1007/s00592-016-0955-9

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  14 in total

1.  Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells.

Authors:  Ilka Engelmann; Enagnon K Alidjinou; Antoine Bertin; Johann Bossu; Céline Villenet; Martin Figeac; Famara Sane; Didier Hober
Journal:  Cell Mol Life Sci       Date:  2017-06-10       Impact factor: 9.261

2.  Role and Significance of Circulating Biomarkers: miRNA and E2F1 mRNA Expression and Their Association with Type-2 Diabetic Complications.

Authors:  Mirza Masroor Ali Beg; Amit Kumar Verma; Mohd Saleem; Fayez Saud Alreshidi; Fahaad Alenazi; Hafiz Ahmad; Prakash C Joshi
Journal:  Int J Endocrinol       Date:  2020-08-20       Impact factor: 3.257

3.  Silencing circRNA LRP6 down-regulates PRMT1 to improve the streptozocin-induced pancreatic β-cell injury and insulin secretion by sponging miR-9-5p.

Authors:  Jianqiang Ma; Yifan Wu; Ying He
Journal:  J Bioenerg Biomembr       Date:  2021-04-07       Impact factor: 2.945

Review 4.  Felix dies natalis, insulin… ceterum autem censeo "beta is better".

Authors:  Lorenzo Piemonti
Journal:  Acta Diabetol       Date:  2021-05-23       Impact factor: 4.280

5.  Insulin micro-secretion in Type 1 diabetes and related microRNA profiles.

Authors:  Andrzej S Januszewski; Yoon Hi Cho; Mugdha V Joglekar; Ryan J Farr; Emma S Scott; Wilson K M Wong; Luke M Carroll; Yik W Loh; Paul Z Benitez-Aguirre; Anthony C Keech; David N O'Neal; Maria E Craig; Anandwardhan A Hardikar; Kim C Donaghue; Alicia J Jenkins
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

6.  Circulating microRNA (miRNA) Expression Profiling in Plasma of Patients with Gestational Diabetes Mellitus Reveals Upregulation of miRNA miR-330-3p.

Authors:  Guido Sebastiani; Elisa Guarino; Giuseppina Emanuela Grieco; Caterina Formichi; Chiara Delli Poggi; Elena Ceccarelli; Francesco Dotta
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-12       Impact factor: 5.555

7.  Level of miR-101a and miR-107 in Human Adipose Mesenchymal Stem Cells Committed to Insulin-producing Cells.

Authors:  Hadi Rajabi; Somayeh Aslani; Reza Rahbarghazi
Journal:  Int J Mol Cell Med       Date:  2021-05-22

8.  MicroRNA Expression Analysis of In Vitro Dedifferentiated Human Pancreatic Islet Cells Reveals the Activation of the Pluripotency-Related MicroRNA Cluster miR-302s.

Authors:  Guido Sebastiani; Giuseppina Emanuela Grieco; Noemi Brusco; Giuliana Ventriglia; Caterina Formichi; Lorella Marselli; Piero Marchetti; Francesco Dotta
Journal:  Int J Mol Sci       Date:  2018-04-12       Impact factor: 5.923

9.  EGF suppresses the expression of miR-124a in pancreatic β cell lines via ETS2 activation through the MEK and PI3K signaling pathways.

Authors:  Lin Yang; Yuansen Zhu; Delin Kong; Jiawei Gong; Wen Yu; Yang Liang; Yuzhe Nie; Chun-Bo Teng
Journal:  Int J Biol Sci       Date:  2019-09-07       Impact factor: 6.580

Review 10.  Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes.

Authors:  Giuseppina Emanuela Grieco; Noemi Brusco; Giada Licata; Laura Nigi; Caterina Formichi; Francesco Dotta; Guido Sebastiani
Journal:  Int J Mol Sci       Date:  2019-12-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.